Publications


Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias.
Pediatr Blood Cancer 2016 Jun 17;63(6):997-1005. Epub 2016 Feb 17.
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland;

Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates.
Invest New Drugs 2016 Feb 10;34(1):61-5. Epub 2015 Dec 10.
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1W-3750, 9000, Rockville Pike, Bethesda, MD, 20892-1104, USA.

Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model.
Cancer Chemother Pharmacol 2011 Jun 20;67(6):1291-7. Epub 2010 Aug 20.
Pediatric Oncology Branch, National Cancer Institute, 10 Center Drive, Building 10/Rm 1W-5750, Bethesda, MD 20892, USA.



Loss of Smad3 in acute T-cell lymphoblastic leukemia.
N Engl J Med 2004 Aug;351(6):552-9
Laboratory of Cell Regulation and Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md, USA.

OF